Thomas J. Mckearn

This profile gathers the share dealings of Thomas J. Mckearn across 2 companies, led by Advaxis, Inc. and Traws Pharma, Inc. We count 11 filings; the first trade dates from 1 March 2012 and the latest from 20 December 2016.

The open-market side counts 1 purchase for €38k alongside 3 sales for €226k. Netting one side against the other leaves €189k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 7 share grants. So far in 2016, the count stands at no purchases and 3 sales.

On 21 December 2016 came the latest disclosure, an open-market sale for €96k in Advaxis, Inc. The last insider purchase was made public on 1 August 2013, 4,848 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.